Latest Outcome Health News
May 3, 2021
His previous primary focus was venture capital and startups. Winkler has had a number of scoops on this beat in the past which drove his interest. One was Elon Musk’s Neuralink while another was Outcome Health, about which he was part of a multi-month investigation, discovered they were misleading customers. Investors sued and the government has already secured three felony guilty pleas and indicted three other executives. Winkler has been at the Journal since July 2010, first working on the “Heard on the Street” column. He previously was a columnist for Reuters and also worked as an analyst for a hedge fund.